GPZL COVID-19 Resources
Challenges and a Path Forward for Leprosy during COVID-19: Working Group 1 Report
GPZL’s Working Group 1, the Leprosy Emergency Operations Committee (LEOC), works to address and resolve issues in the supply of drugs for the treatment of leprosy and leprosy reactions, and other forms of care such as wound care, disability care, … More Challenges and a Path Forward for Leprosy during COVID-19: Working Group 1 Report
The COVID-19 Crisis and Persons Affected by Leprosy Fact Sheet
Persons affected by leprosy have been especially impacted by the worst consequences of the COVID-19 pandemic. Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. The Global Partnership for Zero Leprosy COVID-19 Emergency Response Working Group 2 and UN Special Rapporteur Alice Cruz, gathered data from 100+ persons affected and partners, representing 24 countries on available programmes and resources offering support to persons affected during this time. This fact sheet highlights some of the measures taken by governments and NGOs in the represented countries, and underscores the need for increased support.
Persons Affected & COVID-19 Report
Working Group 2 consulted persons affected by leprosy about pandemic challenges.
Open letter from UN Special Rapporteur on COVID-19 and leprosy
Open letter on COVID-19 and leprosy to the UN Member States from UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz.
Advice about leprosy and COVID-19
Advice about leprosy and COVID-19 from the WHO Global Leprosy Programme, ILEP, UN Special Rapporteur Alice Cruz, and GPZL. Includes guidance on diagnosis and clinical management of leprosy patients, public health aspects of leprosy in the COVID-19 pandemic, and services for persons living with disabilities and/or psychosocial consequences of leprosy.